Company Number: 13091230

Analysis Date: 2025-07-20 18:58 UTC

1. Risk Rating: LOW
   The company demonstrates strong net current assets and shareholder funds with no overdue filings or signs of insolvency. Financial data indicates growing cash reserves and positive equity, supporting a low solvency risk profile.

2. Key Concerns:

• Directors’ current account creditor balance (£75,149) is significant and should be understood in terms of repayment terms and impact on liquidity.
• Corporation tax creditor has increased notably (£89,613), suggesting potential upcoming cash outflows that require monitoring.
• Limited information on turnover, profitability, and cash flow beyond balance sheet limits full assessment of operational performance and sustainability.

3. Positive Indicators:

• Substantial increase in cash reserves from £167k in 2022 to £458k in 2023, indicating strong liquidity.
• Net current assets growth from £61k to £292k and equity increase from £66k to £317k in the latest year reflect a robust financial position.
• Timely submission of accounts and confirmation statements, showing good regulatory compliance.
• Company operates in a specialized medical practice sector (SIC 86220), typically associated with stable demand and skilled professional services.

4. Due Diligence Notes:

• Clarify nature, terms, and expected repayment schedule of director’s current account balance classified as a creditor.
• Review corporation tax liabilities and confirm payment plans or potential disputes.
• Obtain management accounts or profit and loss statements to assess revenue trends and profitability beyond balance sheet analysis.
• Verify if the recent appointment of a new director has led to any strategic or operational changes.
• Confirm absence of any director disqualifications or regulatory issues beyond Companies House filings.